the Institute further expanded its already advanced bioimaging capabilities to include tomography with the acquisition of its The Thermo Fisher Scientific Arctis, a Focused Ion Beam Scanning ...

Seer also announced a co-marketing and sales agreement with Thermo Fisher Scientific to jointly promote Proteograph alongside ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” third quarter 2024 investor ...

Thermo Fisher Scientific (NYSE:TMO) traded lower in the premarket on Wednesday as the Waltham, Massachusetts-based healthcare giant reaffirmed its 2024 revenue outlook after falling short of ...

I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact ...

Thermo Fisher Scientific TMO is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.

Thermo Fisher Scientific Inc.'s TMO third-quarter 2024 adjusted earnings per share (EPS) of $5.28 beat the Zacks Consensus Estimate by 0.6%. However, the figure decreased 7.2% year over year.

Guidance: Thermo Fisher reaffirms its 2024 sales guidance of $42.4 billion—$43.3 billion, compared to the consensus of $42.91 billion. The life science company revised its adjusted EPS guidance ...